Fortress Biotech, Inc.
FBIO
$2.29
$0.073.15%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 41.80% | 145.47% | 241.45% | 31.35% | 27.09% |
| Total Depreciation and Amortization | 2.84% | 20.90% | -2.94% | 0.00% | -5.62% |
| Total Amortization of Deferred Charges | 13.00% | -17.99% | -40.34% | -51.56% | -40.94% |
| Total Other Non-Cash Items | 138.28% | -200.57% | -265.80% | 57.07% | 80.07% |
| Change in Net Operating Assets | -88.47% | 18.71% | -172.98% | -152.60% | 68.42% |
| Cash from Operations | 2.81% | 69.54% | -26.20% | 22.94% | 63.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -42,757.14% |
| Cash from Investing | 100.00% | -- | -- | -- | -23,709.52% |
| Total Debt Issued | -- | -- | -- | -- | -65.57% |
| Total Debt Repaid | 108.80% | 79.20% | -- | -- | -786.81% |
| Issuance of Common Stock | -38.87% | -77.60% | -73.40% | -89.93% | -92.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 100.00% |
| Other Financing Activities | -74.75% | 134.91% | -55.11% | 177.10% | -6.14% |
| Cash from Financing | -77.88% | 455.96% | -68.31% | 87.16% | -40.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -225.42% | 168.20% | -123.86% | 1,265.05% | -124.37% |